Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

MRI safety: nephrogenic systemic fibrosis and other risks.

Gauden AJ, Phal PM, Drummond KJ.

J Clin Neurosci. 2010 Sep;17(9):1097-104. doi: 10.1016/j.jocn.2010.01.016. Review.

PMID:
20542435
2.

Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.

Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R.

J Am Coll Cardiol. 2009 May 5;53(18):1621-8. doi: 10.1016/j.jacc.2008.12.061. Review.

3.

Nephrogenic systemic fibrosis and gadolinium-based contrast agents.

Abu-Alfa AK.

Adv Chronic Kidney Dis. 2011 May;18(3):188-98. doi: 10.1053/j.ackd.2011.03.001. Review.

PMID:
21531325
4.
5.

Removal of gadolinium by dialysis: review of different strategies and techniques.

Silberzweig JI, Chung M.

J Magn Reson Imaging. 2009 Dec;30(6):1347-9. doi: 10.1002/jmri.21981. Review.

PMID:
19937933
6.

Nephrogenic systemic fibrosis and its impact on abdominal imaging.

Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.

Radiographics. 2009 Oct;29(6):1565-74. doi: 10.1148/rg.296095517. Review.

PMID:
19959508
7.

Application of extracellular gadolinium-based MRI contrast agents and the risk of nephrogenic systemic fibrosis.

Heverhagen JT, Krombach GA, Gizewski E.

Rofo. 2014 Jul;186(7):661-9. doi: 10.1055/s-0033-1356403. Review.

8.

[Nephrogenic fibrosing dermopathy or nephrogenic systemic fibrosis? What do we know and what do we have to learn?].

Ortega LM, Contreras G, Lenz O.

Nefrologia. 2009;29(2):109-17. doi: 10.3265/Nefrologia.2009.29.2.4842.en.full. Review. Spanish.

9.

[Nephrogenic systemic fibrosis: a rare disease with grave consequences].

Kielstein JT, Schiffer M.

Internist (Berl). 2010 Jan;51(1):39-44. doi: 10.1007/s00108-009-2408-9. German.

PMID:
20033388
10.

Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents.

Penfield JG.

Pediatr Nephrol. 2008 Dec;23(12):2121-9. doi: 10.1007/s00467-008-0862-6. Review.

PMID:
18543004
11.

Gadolinium-associated nephrogenic systemic fibrosis.

Schlaudecker JD, Bernheisel CR.

Am Fam Physician. 2009 Oct 1;80(7):711-4.

12.

Nephrogenic systemic fibrosis: clinical spectrum of disease.

Mayr M, Burkhalter F, Bongartz G.

J Magn Reson Imaging. 2009 Dec;30(6):1289-97. doi: 10.1002/jmri.21975. Review.

PMID:
19937929
13.

Current status of gadolinium toxicity in patients with kidney disease.

Perazella MA.

Clin J Am Soc Nephrol. 2009 Feb;4(2):461-9. doi: 10.2215/CJN.06011108. Review. Erratum in: Clin J Am Soc Nephrol. 2009 Apr;4(4):866.

14.

Nephrogenic systemic fibrosis and the role of gadolinium contrast media.

van der Molen AJ.

J Med Imaging Radiat Oncol. 2008 Aug;52(4):339-50. doi: 10.1111/j.1440-1673.2008.01965.x. Review.

PMID:
18811757
16.

Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?

Panesar M, Boateng F, Patel SS, Masood SF, Mahajan P, Patel N, Murray B.

Hemodial Int. 2010 Jul;14(3):289-94. doi: 10.1111/j.1542-4758.2010.00456.x.

PMID:
20662951
17.

Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.

Chen W, Huang SL, Huang CS, Tsai MC, Lai HM, Lui CC, Eng HL, Chang HW, Lee CH, Chuang FR.

Eur J Dermatol. 2009 Jan-Feb;19(1):44-9. doi: 10.1684/ejd.2008.0545.

PMID:
19059824
18.

Nephrogenic systemic fibrosis and management of high-risk patients.

Altun E, Semelka RC, Cakit C.

Acad Radiol. 2009 Jul;16(7):897-905. doi: 10.1016/j.acra.2009.01.001. Review.

PMID:
19375360
19.

MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety.

Juluru K, Vogel-Claussen J, Macura KJ, Kamel IR, Steever A, Bluemke DA.

Radiographics. 2009 Jan-Feb;29(1):9-22. doi: 10.1148/rg.291085072.

PMID:
19019996
20.

Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST study.

Janus N, Launay-Vacher V, Karie S, Clement O, Ledneva E, Frances C, Choukroun G, Deray G.

Eur J Radiol. 2010 Feb;73(2):357-9. doi: 10.1016/j.ejrad.2008.11.021.

PMID:
19128909
Items per page

Supplemental Content

Support Center